This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Dynegy: Pump Up The Volume

HOUSTON ( TheStreet) -- Dynegy (DYN - Get Report) finished Thursday's session with gains on heavy volume on reports of a possible acquisition by NRG Energy (NRG - Get Report).

Dynegy saw 44.4 million shares change hands Thursday, more than three times its three-month daily average, after Briefing.com reported market chatter about a NRG-for-Dynegy deal. Volume was greatest during the first half hour of trading, when Dynegy's stock hit an intraday high of $2.42. Shares pared gains but finished higher by 3 cents, or 1.3%, at $2.27.

Briefing.com also noted that Dynegy Oct. 2009 calls were seeing greater interest than puts on the rumor.

Dynegy has a 840.2 million-share float with a small short interest float of 2.6% as of Aug. 26, according to Yahoo! Finance. NRG, on the other hand, has a float of 264 million and a short interest float of 6.5%. NRG has a market cap of $7.2 billion, compared to Dynegy's $1.9 billion market cap.

Investor posts on Internet message boards Thursday noted that short interest in Dynegy is considerably smaller than it was a year ago. Others argued that any takeover of Dynegy would see shares fetch a price between $4 and $5. Dynegy shares have a 52-week high of $4.30.

China BAK Rides A123's Coatails

China BAK Battery (CBAK - Get Report) was trading sharply lower on above-average volume following the initial public offering of rival battery maker A123 Systems (AONE).

A123 shares jumped 53.8% to $20.76 in its debut. The maker of rechargeable lithium-ion batteries raised $380 million by offering 28.2 million shares. China BAK shares had surged into A123's IPO, rising nearly 30% Wednesday on heavy volume.

However, China BAK shares were lately down 42 cents, or 10.6%, to $3.56. More than 1.7 million changed hands, compared to the stock's 50-day average daily volume of 231,000, according to the Nasdaq's Web site. China BAK has a 37.7 million-share float with a small short interest float of 2.9% as of Aug. 11, according to Yahoo! Finance.

Investor posts on Internet message boards called Wednesday's rally in China BAK shares a "fluke." Others noted that insiders own more than 30% of the company. One commenter noted that A123's surge Thursday gave it a market cap well above China BAK's market share, which stands at $206 million, and argued that China BAK's should be greater.

Keryx Biopharmaceuticals Trades Down on Heavy Volume

Keryx Biopharmaceuticals (KERX - Get Report) was trading lower Thursday on above-average volume one day after the company announced results of a successful trial of its kidney disease drug.

On Wednesday, Keryx said trial results indicated that long-term use of its Zerenex kidney disease drug for hyperphosphatemia, or elevated phosphate levels in the blood, can keep patients within the normal serum phosphorous range for extended periods of time and that the drug appears to be well-tolerated.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
DYN $32.69 -0.88%
CBAK $3.32 0.61%
KERX $10.33 -3.10%
NRG $25.97 -0.50%
AAPL $132.54 0.88%

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs